Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 1—January 2005

Research

Multidrug-Resistant Acinetobacter baumannii

Aharon Abbo*, Shiri Navon-Venezia*, Orly Hammer-Muntz*, Tami Krichali*, Yardena Siegman-Igra*, and Yehuda Carmeli*Comments to Author 
Author affiliations: *Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Main Article

Table 3

Multivariate analysis for risk factors for Acinetobacter baumannii*†

Parameter‡ OR 95% CI p value
Male sex 3.84 1.63–8.99 0.002
Ischemic heart disease 3.35 1.44–7.77 0.005
Mechanical ventilation 6.27 2.27–17.33 <0.001
Penicillin use§ 0.38 0.16–0.90 0.029
Metronidazole use 2.33 0.98–5.83 0.071
Any home antimicrobial drug treatment 4.74 1.31–17.15 0.018

*OR, odds ratio; CI, confidence interval.
†Adjusted for length of hospital stay prior to entry to the study.
‡All parameters had been present before A. baumannii identification.
§Including semisynthetics with or without a β-lactamase inhibitor (never sulbactam).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO